Loading
Urologist behind PROMIS and PRECISION, which put MRI before biopsy in the prostate cancer pathway.
Mark Emberton was senior investigator of PROMIS and PRECISION, the trials showing that multiparametric MRI before biopsy detects more clinically significant prostate cancers and fewer insignificant ones than standard systematic biopsy, which rewrote diagnostic guidelines worldwide. He pioneered focal therapy with HIFU and cryotherapy and leads interventional oncology research at UCL.
Shares Rakesh Heer, Caroline Moore, PRECISION, PROMIS and the tags prostate, imaging, focal-therapy.
Shares Rakesh Heer, University College London Hospitals / UCL Cancer Institute, MRI, Prostate cancer and the tag prostate.
Shares Prostate cancer and the tags prostate, imaging.
Shares University College London Hospitals / UCL Cancer Institute, Prostate cancer and the tag prostate.
Shares Focused ultrasound & histotripsy, MRI, Prostate cancer.
Shares PRECISION, PROMIS: diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer, Prostate cancer.
Shares Prostate cancer and the tag prostate.
Shares Prostate cancer and the tag prostate.